These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26715463)

  • 1. US panel recommends statins for adults aged 40 to 75 at 10% or greater risk of cardiovascular disease.
    McCarthy M
    BMJ; 2015 Dec; 351():h7008. PubMed ID: 26715463
    [No Abstract]   [Full Text] [Related]  

  • 2. Reinitiation of statins after statin-associated musculoskeletal symptoms: a patient-centered approach.
    Brito JP; Montori VM
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):243-7. PubMed ID: 23481527
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of statins on renal function].
    Kasahara M
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1295-300. PubMed ID: 24288966
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are therapeutic LDL goals justified? Controversies between the European and American guidelines].
    Bertomeu-Martínez V
    Medwave; 2016 Dec; 16(Suppl4):e6825. PubMed ID: 28055995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for millions more?
    Lancet; 2014 Feb; 383(9918):669. PubMed ID: 24560042
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Burstein B; Altobelli KK; Williams K; Cannon CP; Pencina MJ; Sniderman AD; Thanassoulis G
    Circulation; 2017 Nov; 136(19):1860-1862. PubMed ID: 29109198
    [No Abstract]   [Full Text] [Related]  

  • 7. Questioning the benefits of statins.
    Mazowita G
    CMAJ; 2005 Nov; 173(10):1210; author reply 1210. PubMed ID: 16275979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].
    Shoji T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1267-75. PubMed ID: 24288962
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recommendations for management of dyslipidemia in 2016 in Switzerland].
    Aubert CE; Gencer B; Rodondi N
    Rev Med Suisse; 2016 Mar; 12(508):430-4. PubMed ID: 27089598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Disorders: Screening and Treatment.
    Jin J
    JAMA; 2016 Nov; 316(19):2056. PubMed ID: 27838718
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins: new American guidelines for prevention of cardiovascular disease.
    Ridker PM; Cook NR
    Lancet; 2013 Nov; 382(9907):1762-5. PubMed ID: 24268611
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
    ; Bibbins-Domingo K; Grossman DC; Curry SJ; Davidson KW; Epling JW; García FAR; Gillman MW; Kemper AR; Krist AH; Kurth AE; Landefeld CS; LeFevre ML; Mangione CM; Phillips WR; Owens DK; Phipps MG; Pignone MP
    JAMA; 2016 Nov; 316(19):1997-2007. PubMed ID: 27838723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk stratification in overweight or obese patients in primary prevention. Implications for use of statins.
    Masson W; Lobo M; Huerín M; Molinero G; Manente D; Pángaro M; Vitagliano L; Zylbersztejn H
    Endocrinol Nutr; 2015 Feb; 62(2):83-90. PubMed ID: 25573227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins for primary prevention of cardiovascular disease.
    Byrne P; Cullinan J; Smith SM
    BMJ; 2019 Oct; 367():l5674. PubMed ID: 31619406
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins.
    Ratchford EV; Martin SS
    Vasc Med; 2017 Oct; 22(5):442-445. PubMed ID: 28803537
    [No Abstract]   [Full Text] [Related]  

  • 17. Determining optimal threshold for statins prescribing: individualization of statins treatment for primary prevention of cardiovascular disease.
    Djulbegovic B; Tsalatsanis A; Hozo I
    J Eval Clin Pract; 2017 Apr; 23(2):241-250. PubMed ID: 26555150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When should we start the treatment of the cardiovascular risk factors].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2008; 125(1):125-36; discussion 136-44. PubMed ID: 18777847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Starting statins for primary prevention of cardiovascular disease.
    Tunstall-Pedoe H
    Heart; 2013 Nov; 99(21):1547-8. PubMed ID: 23878178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.